Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-07-15Clinical Trial Update: A Study of the Pan-immunotherapy in Patients With Relapsed/Refractory Ovarian Cancer [Phase 2]
An update on a Phase 2 study evaluating a pan-immunotherapy in patients with relapsed/refractory ovarian cancer; the trial status is complet…
-
CLINICAL_TRIALS trial_result · 2024-07-12Clinical Trial Update: A Trial of Weekly Paclitaxel With Oncothermia and Weekly cisPlatin With Oncothermia in Patients With Recurrent or Persistent Ovarian Cancer [Phase 1]
This Phase 1 trial update reports completion of a study evaluating weekly paclitaxel with oncothermia and weekly cisplatin with oncothermia …
-
CLINICAL_TRIALS trial_result · 2024-07-09Clinical Trial Update: Study of RO7515629 in Participants With HLA-G Positive Solid Tumors [Phase 1]
This Phase 1 study of RO7515629 in participants with HLA-G positive solid tumors has been terminated. The trial enrolled patients with renal…
-
CLINICAL_TRIALS trial_result · 2024-07-08Clinical Trial Update: HRD Status Reference Standard Based on WGS
This clinical trial completed evaluation of an HRD status reference standard based on whole-genome sequencing for ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer [Phase 2]
A Phase 2 clinical trial evaluates adding anlotinib to standard carboplatin/paclitaxel chemotherapy as first-line therapy for advanced ovari…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-07-03Clinical Trial Update: A Biomarker Exploration Study of Precision Treatment in Ovarian Cancer
A clinical trial exploring biomarkers for precision treatment in ovarian cancer is active but not recruiting.
-
CLINICAL_TRIALS research · 2024-07-03Clinical Trial Update: Ultrasound-guided Tru-Cut Biopsy in Pelvic Masses.
Trial status update indicates that a study using ultrasound-guided Tru-Cut biopsy for pelvic masses is recruiting, involving patients with o…
-
CLINICAL_TRIALS trial_result · 2024-06-25Clinical Trial Update: CLDN6/GPC3/Mesothelin/AXL-CAR-NK Cell Therapy for Advanced Solid Tumors [Phase 1]
A phase 1 trial evaluating CLDN6/GPC3/Mesothelin/AXL-CAR-NK cell therapy for advanced solid tumors is currently recruiting, including stage …
-
CLINICAL_TRIALS research · 2024-06-25Clinical Trial Update: Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors [Phase 1, Phase 2]
Clinical trial update for a triplex checkpoint inhibitor therapy evaluating safety and efficacy in advanced solid tumors, currently recruiti…
-
CLINICAL_TRIALS research · 2024-06-25Clinical Trial Update: Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors [Phase 2, Phase 3]
Clinical trial update for a Phase 2/Phase 3 study examining trans-arterial/intra-tumor infusion of checkpoint inhibitors plus chemotherapy f…
-
CLINICAL_TRIALS research · 2024-06-21Clinical Trial Update: An Exploratory Clinical Study of Statins for Improving Chemotherapy and Maintenance in Patients With Ovarian Cancer [Phase 2]
Phase 2 exploratory clinical study evaluating whether adding statins to chemotherapy and maintenance improves outcomes for patients with ova…
-
CLINICAL_TRIALS research · 2024-06-20Clinical Trial Update: A Cohort Establishment Study of Total Management of Ovarian Cancer
A recruiting cohort establishment study at Sichuan Cancer Hospital and Research Institute investigating total management of ovarian cancer.
-
CLINICAL_TRIALS research · 2024-06-17Clinical Trial Update: Phase 1 Study to Evaluate the Safety, Feasibility and Immunogenicity of an Allogeneic, Cell-based Vaccine (DCP-001) in High Grade Serous Ovarian Cancer Patients After Primary Treatment [Phase 1]
Phase 1 clinical trial evaluating the safety, feasibility, and immunogenicity of DCP-001, an allogeneic cell-based vaccine, in patients with…
-
CLINICAL_TRIALS research · 2024-06-13Clinical Trial Update: Identification of Risk Factors and Construction of Prediction Model for Postoperative Intestinal Anastomotic Leakage in Ovarian Cancer
Clinical trial investigating risk factors for postoperative intestinal anastomotic leakage in ovarian cancer and developing a predictive mod…
-
CLINICAL_TRIALS research · 2024-06-12Clinical Trial Update: Pharmacokinetic Boosting of Olaparib to Improve Exposure, Tolerance and Cost-effectiveness [Phase 4]
A Phase 4 clinical trial is evaluating a pharmacokinetic boosting strategy for olaparib to improve exposure and tolerability, with a focus o…
-
CLINICAL_TRIALS research · 2024-06-11Clinical Trial Update: Vaccination of Patients With Ovarian Cancer With Dendritic Cell/Tumor Fusions With Granulocyte Macrophage Colony-stimulating Factor (GM-CSF) and Imiquimod [Phase 2]
Phase 2 clinical trial evaluating a dendritic cell/tumor fusion vaccine with GM-CSF and Imiquimod for ovarian cancer, primary peritoneal can…
-
CLINICAL_TRIALS research · 2024-06-06Clinical Trial Update: Early Detection of Relapse in Ovarian Cancer Using Capillary Home-sampling and a Protein Biomarker Test
A clinical trial is evaluating capillary home-sampling combined with a protein biomarker test for early detection of relapse in ovarian canc…
-
CLINICAL_TRIALS research · 2024-06-06Clinical Trial Update: Adebrelimab Plus Chemotherapy, Bevacizumab and Fluzoparib in Platinum-Sensitive Relapsed Ovarian Cancer [Phase 2]
Phase 2 clinical trial evaluating adebrelimab in combination with chemotherapy, bevacizumab, and fluzoparib for platinum-sensitive relapsed …
-
CLINICAL_TRIALS trial_result · 2024-05-29Clinical Trial Update: Neo-adjuvant Pembrolizumab in Primary Stage IV Ovarian Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating neo-adjuvant pembrolizumab in primary stage IV ovarian cancer with peritoneal or fallopian tube involvement. The …
-
CLINICAL_TRIALS trial_result · 2024-05-24Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies [Phase 1]
This Phase 1 trial evaluated the safety and tolerability of immunotherapy combinations across multiple advanced cancers and has completed.
-
CLINICAL_TRIALS trial_result · 2024-05-24Clinical Trial Update: A Study to Evaluate Safety/Tolerability of Immunotherapy Combinations in Participants With Triple-Negative Breast Cancer or Gynecologic Malignancies [Phase 1]
Phase 1 study evaluating safety and tolerability of immunotherapy combinations in triple-negative breast cancer and ovarian cancer has compl…
-
CLINICAL_TRIALS trial_result · 2024-05-23Clinical Trial Update: Efficacy and Safety of SBRT in Oligo-metastatic/Persistent/Recurrent Ovarian Cancer [NA]
A completed clinical trial evaluated the efficacy and safety of stereotactic body radiotherapy (SBRT) in patients with oligo-metastatic/pers…
-
CLINICAL_TRIALS research · 2024-05-21Clinical Trial Update: A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating ILB2109 in combination with toripalimab in patients with advanced solid malignancies, currently recrui…
-
CLINICAL_TRIALS research · 2024-05-20Clinical Trial Update: RC48 Treatment for Platinum Sensitive Recurrent Ovarian Cancer With HER2 Expression [Phase 2]
A Phase 2 clinical trial update for RC48 (disitamab vedotin) in platinum-sensitive recurrent ovarian cancer expressing HER2; the study is cu…
-
CLINICAL_TRIALS research · 2024-05-20Clinical Trial Update: Evaluation of Amino Acid Metabolism Changes in Ovarian Cancer [NA]
A clinical trial is evaluating amino acid metabolism changes in ovarian cancer and is currently recruiting. The study is sponsored by Univer…